https://www.buffalo.edu/news/releases/2023/09/UB-research-semaglutide-Type-1-diabetes-insulin.html
0
0
9/6/23 at 9:55pm
Organization
University at Buffalo Reporter
39 words
0
Comments
Treating newly diagnosed Type 1 diabetes patients with semaglutide may drastically reduce or even eliminate their need for injected insulin.
You are the first to view
Create an account
or login to join the discussion